pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·2h ago·1 min read
save

Podcast examines growing US mistrust in science and a new gene-editing lawsuit

Oct 1, 2026·read at STAT ↗Neutral

The latest episode of The Readout LOUD, a weekly biotech podcast, focused on the erosion of public confidence in science.

Hosts Adam Feuerstein, Elaine Chen, and Allison DeAngelis spoke with STAT’s newly appointed trust‑in‑science reporter Nicholas Florko about factors driving skepticism and how political leaders may have amplified doubts.

The conversation also touched on a recent lawsuit involving gene‑editing technology, highlighting legal challenges that could affect the field’s perception.

In addition, the team provided a brief clinical update from UniQure, though details were limited in the excerpt.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Mistrust in science and a juicy gene-editing lawsuit”

read at STAT ↗
546 words · retrieved 1h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
NOVO3ELI LILLY CO2LILLY2Novo Nordisk Inc2Beam Therapeutics Inc.NOVARTIS
drugs
Obesity3
topics
Obesity3CRISPR/Cas9CardiologyGLP-1 receptorGene Therapy (AAV)

related stories

  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • Sep 17Novo notches up to $1.4B pact with Orbis to develop oral macrocycle cardiometabolic drugsBioSpace
  • Sep 15FDA clears first generic radioligand drug; Sionna turns to layoffsBioPharma Dive
  • Sep 10Why two promising heart drugs flopped and what’s nextSTAT
  • Aug 28STAT+: Pharmalittle: We’re reading about an AstraZeneca trial failure, a ‘monstrous’ conflict of interest, and moreSTAT